Increased Tissue Arachidonic Acid and Reduced Linoleic Acid in a Mouse Model of Cystic Fibrosis Are Reversed by Supplemental Glycerophospholipids Enriched in Docosahexaenoic Acid (original ) (raw )Increased tissue arachidonic acid and reduced linoleic acid in a mouse model of cystic fibrosis are reversed by supplemental glycerophospholipids enriched in …
teresinha leal
The Journal of …, 2009
View PDFchevron_right
Oral DHA supplementation in deltaF 508 homozygous cystic fibrosis patients
Saskia Vande Velde
Acta Gastro-enterologica Belgica, 2008
View PDFchevron_right
Low linoleic and high docosahexaenoic acids in a severe phenotype of transgenic cystic fibrosis mice
Mohamed ALi
Experimental biology and medicine (Maywood, N.J.), 2018
View PDFchevron_right
Not Just any Fat for Cystic Fibrosis? Docosahexaenoic Acid in Cystic Fibrosis
Jean Pierre Van Biervliet , Eddy Robberecht , Stephanie Van Biervliet
Current Pediatric Reviews, 2006
View PDFchevron_right
Docosahexaenoic acid trials in cystic fibrosis: A review of the rationale behind the clinical trials
Stephanie Van Biervliet
Journal of Cystic Fibrosis, 2005
View PDFchevron_right
Changes of Erythrocyte Fatty Acids after Supplementation with Highly Concentrated Docosahexaenoic Acid (DHA) in Pediatric Cystic Fibrosis: A Randomized Double-Blind Controlled Trial
Oscar Asensio de la Cruz
Journal of Clinical Medicine
View PDFchevron_right
Linoleic acid supplementation results in increased arachidonic acid and eicosanoid production in CF airway cells and in cftr-/- transgenic mice
Abdul Malik Bhutta
AJP: Lung Cellular and Molecular Physiology, 2010
View PDFchevron_right
The absorption and effect of dietary supplementation with omega-3 fatty acids on serum leukotriene B4, in patients with cystic fibrosis
Maurice Bennink
Pediatric Pulmonology, 1994
View PDFchevron_right
Increasing Dietary α-Linolenic Acid Enhances Tissue Levels of Long-Chain n-3 PUFA when Linoleic Acid Intake Is Low in Hamsters
Valerie Casey
Annals of Nutrition and Metabolism, 2010
View PDFchevron_right
Upregulated liver conversion of -linolenic acid to docosahexaenoic acid in rats on a 15 week n-3 PUFA-deficient diet
Miki Igarashi
The Journal of Lipid Research, 2006
View PDFchevron_right
Persistence of Essential Fatty Acid Deficiency in Cystic Fibrosis Despite Nutritional Therapy
Jose Luis Prieto
Pediatric Research, 2009
View PDFchevron_right
LONG-TERM DOCOSAHEXAENOIC ACID THERAPY IN A CONGENIC MURINE MODEL OF CYSTIC FIBROSIS
Catherine Luk , Peter Durie
2000
View PDFchevron_right
A comprehensive evaluation of omega-3 fatty acid supplementation in cystic fibrosis patients using lipidomics
ADELAIDA FERREIRO
The Journal of Nutritional Biochemistry, 2019
View PDFchevron_right
Comparative effects of high oleic acid vs high mixed saturated fatty acid obesogenic diets upon PUFA metabolism in mice
Joseph Idso
Prostaglandins, leukotrienes, and essential fatty acids, 2017
View PDFchevron_right
Fatty acids platelets and oxidative markers following intravenous n-3 fatty acids administration in cystic fibrosis: An open pilot observational study
Eric Fontaine
Journal of Cystic Fibrosis, 2007
View PDFchevron_right
Effect of dietary docosahexaenoic acid on desaturation and uptake in vivo of isotope-labeled oleic, linoleic, and linolenic acids by male subjects
Edward Emken
Lipids, 1999
View PDFchevron_right
A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr-/- mice
Eliza Parker
Proceedings of the National Academy of Sciences, 1999
View PDFchevron_right
Increased Δ5- and Δ6-desaturase, cyclooxygenase-2, and lipoxygenase-5 expression and activity are associated with fatty acid and eicosanoid changes in cystic fibrosis
michael njoroge
Biochimica Et Biophysica Acta-molecular and Cell Biology of Lipids, 2011
View PDFchevron_right
Fatty acid composition of serum phospholipids in cystic fibrosis (CF) patients with or without CF related liver disease
Stephanie Van Biervliet
Clinical Chemistry and Laboratory Medicine, 2010
View PDFchevron_right
Abnormal Fatty-Acid Composition of Plasma-Lipids in Cystic Fibrosis
Van Hubbard
The Lancet, 1977
View PDFchevron_right
What is the association of essential fatty acid status with cystic fibrosis?
Van Hubbard
European Journal of Pediatrics, 1983
View PDFchevron_right
Evidence of increased flux to n-6 docosapentaenoic acid in phospholipids of pancreas from cftr −/− knockout mice
Mario ollero
Metabolism-clinical and Experimental, 2006
View PDFchevron_right
The effect of varying ratios of docosahexaenoic acid and arachidonic acid in the prevention and reversal of biochemical essential fatty acid deficiency in a murine model
Bruce Bistrian
Metabolism: clinical and experimental, 2013
View PDFchevron_right
Fatty Acid Metabolism in Cystic Fibrosis
Birgitta Strandvik
The New England Journal of Medicine, 2004
View PDFchevron_right
Impact of the -3 to -6 Polyunsaturated Fatty Acid Ratio on Cytokine Release in Human Alveolar Cells
Giuliana Muzio
Journal of Parenteral and Enteral Nutrition, 2011
View PDFchevron_right
Vegetable oils rich in alpha linolenic acid allow a higher accretion of n-3 LCPUFA in the plasma, liver and adipose tissue of the rat
JULIO SANHUEZA
Grasas y Aceites, 2014
View PDFchevron_right
The role of essential fatty acids in cystic fibrosis and normalizing effect of fenretinide
Juan De Sanctis
Cellular and Molecular Life Sciences, 2020
View PDFchevron_right
An overview of monitoring and supplementation of omega 3 fatty acids in cystic fibrosis
Pierre Wallemacq , Teresinha Leal
Clinical Biochemistry, 2007
View PDFchevron_right